Protect the therapy keeping millions of Americans off fentanyl.
The DEA has moved to place 7-hydroxymitragynine (7-OH) on Schedule I — the same category as heroin — and its ban can take effect as early as August 5. More than a million Americans rely on it for chronic pain and to stay off stronger opioids. Add your name in 30 seconds.
5,231 people have added their name — and counting
We’ve beaten this exact ban before.
In 2016, the DEA moved to place 7-OH and its parent plant, kratom, on Schedule I — the same move happening now. It never took effect. More than 142,000 people signed a petition to the White House and over 23,000 filed public comments — 99% against the ban. Under that pressure, the DEA did something it almost never does: it withdrew the ban. The number of people who spoke up is what did it.
Sources: Federal Register — DEA withdrawal notice, Oct 13, 2016 · Pain News Network
Your name is how we do it again.
the earliest the DEA's temporary ban can take effect
Americans use 7-OH for chronic pain or to stay off stronger opioids
the last time this happened, public pressure made the DEA stand down
The DEA is using a temporary-scheduling shortcut that covers products above a small threshold — more than 1 milligram of 7-OH per unit for tablets — and skips public comment entirely. Our position is regulation, not prohibition: age limits, potency caps, testing, honest labeling. Read the DEA’s notice →
“Not numb. Not high. Present.”
“For the first time in 20 years I feel like myself. Not numb, not high. I'm present for the first time in memory.”
“I felt present, balanced, and in control. I wasn't high. I wasn't numb. I was me again.”
“After 13 years on prescription opioids, 7-OH is how I finally stopped.”
Thirty seconds now. A therapy protected for more than a million Americans.
Sign, file your comment, reach your representatives, and pass it on — we’ll walk you through all four.
Add your name5,231 people have added their name — and counting